Price Alert

Globus Medical Inc. (GMED)

NYSE: GMED · Real-Time Price · USD

60.78

0.76 (1.27%)

At close: Aug 15, 2025, 3:12 PM

Globus Medical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	2.63B	2.51B	2.52B	2.48B	2.24B	1.9B	1.57B	1.23B	1.1B	1.07B	1.02B	998.37M	973.94M	961.31M	958.1M	941.53M	927.9M	825.81M
Cost of Revenue	948.92M	959.71M	1.04B	1.13B	961.79M	748.51M	548.17M	353.28M	283.39M	275.38M	263.73M	254.93M	247.99M	243.36M	239.22M	238.29M	236.83M	223.63M
Gross Profit	1.68B	1.55B	1.48B	1.35B	1.27B	1.15B	1.02B	873.16M	813.56M	793.6M	759.12M	743.44M	725.95M	717.94M	718.88M	703.24M	691.07M	602.18M
Operating Income	281.49M	255M	165.99M	115.84M	68.15M	84.74M	133.14M	177.05M	236.34M	237.91M	227.95M	192.12M	185.75M	163.85M	171.95M	212.29M	208.97M	137.53M
Interest Income	1.68M	1.68M	n/a	n/a	7.92M	16.21M	16.21M	16.21M	8.29M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	373.54M	232.95M	120.72M	121.05M	66.55M	93.65M	165.39M	202.51M	261.44M	257.31M	243.02M	200.73M	193.72M	172.11M	180.41M	222.79M	221.47M	150.59M
Net Income	356.65M	185.56M	102.98M	91.51M	40.67M	66.63M	122.87M	157.9M	204.34M	201.22M	190.17M	155.21M	154.99M	141.95M	149.19M	187.04M	184.05M	121.67M
Selling & General & Admin	1.04B	975.14M	981.05M	972.28M	887.75M	769.7M	643.41M	516.77M	467.14M	453.79M	432.12M	420.6M	410.47M	411.01M	408.15M	393.64M	386.34M	359.11M
Research & Development	141.8M	139.55M	151.15M	170M	163.95M	147.6M	124.01M	91.27M	80.64M	76.69M	73.02M	104.53M	101.68M	99.83M	97.35M	61.56M	60.13M	84.04M
Other Expenses	120.46M	123.88M	94.02M	43.95M	106.26M	106.98M	112.94M	81.28M	19.05M	22.73M	21.28M	9.12M	8.96M	4.88M	580K	635K	921K	813K
Operating Expenses	1.3B	1.24B	1.23B	1.19B	1.16B	1.03B	884.19M	693.15M	574.9M	557.45M	530.66M	542.92M	530.19M	529.1M	524.02M	473.96M	464.81M	460.98M
Interest Expense	653K	2.29M	4.19M	7.58M	6.81M	12.77M	10.88M	8.29M	8.29M	2.48M	5.02M	6.96M	9.06M	9.13M	9.3M	25.63M	26.61M	27.66M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.29B	2.25B	2.35B	2.36B	2.17B	1.81B	1.43B	1.05B	858.29M	832.83M	794.38M	797.85M	778.17M	772.47M	763.24M	712.25M	701.64M	684.61M
Income Tax Expense	16.89M	47.38M	17.74M	29.54M	25.88M	27.02M	42.52M	44.61M	57.11M	56.09M	52.85M	45.52M	38.73M	30.16M	31.22M	35.75M	37.42M	28.93M
Shares Outstanding (Basic)	135.21M	136.76M	136.73M	135.62M	135.19M	135.36M	137.88M	113.54M	100.37M	100.28M	99.97M	99.65M	100.67M	101.6M	101.5M	101.1M	100.45M	99.87M
Shares Outstanding (Diluted)	136.5M	139.77M	139.71M	138.06M	136.98M	135.36M	139.02M	115.25M	101.78M	102.2M	102.21M	101.42M	102.88M	104.08M	104.19M	104.42M	103.47M	102.42M
EPS (Basic)	2.62	1.35	0.75	0.67	0.30	0.64	1.18	1.57	2.04	2.01	1.89	1.54	1.53	1.40	1.48	1.87	1.85	1.23
EPS (Diluted)	2.60	1.34	0.75	0.67	0.30	0.64	1.17	1.55	2.01	1.97	1.86	1.51	1.49	1.36	1.43	1.81	1.80	1.19
EBITDA	731.64M	586.34M	470.8M	376.78M	347.18M	320.93M	348.2M	328.2M	318.48M	318.7M	308.37M	272.56M	266.98M	247.57M	253.91M	288.41M	284.94M	206.67M
EBIT	459.76M	321.5M	216.78M	118.2M	118.16M	137.42M	201.85M	237.72M	247.81M	249.17M	240.12M	204.39M	199.63M	178.03M	184.04M	218.47M	215.45M	141.2M
Depreciation & Amortization	271.88M	264.84M	254.03M	256.96M	227.4M	181.89M	144.73M	90.48M	70.67M	69.52M	68.25M	68.17M	67.34M	69.55M	69.87M	69.94M	69.49M	65.46M